Weekly CEO & CFO Moves (Dec 8)

by | Dec 8, 2023

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

CEO Moves

CENTURY THERAPEUTICS INC (IPSC)
Leaving: CEO – Gregory Russotti ( .7 yrs *interim; -61.8% TSR)
Replaced by: Brent Pfeiffenberger
Dr. Pfeiffenberger, age 46, has served as Chief Operating Officer of Neogene Therapeutics Inc., a clinical-stage biotechnology company since May 2021. Prior to this, Dr. Pfeiffenberger held various positions at Bristol Myers Squibb Company, a global biopharmaceutical company, including Senior Vice President and Head of U.S. Oncology from October 2019 until May 2021; Co-Lea…read full bio

GAIA INC (GAIA)
Leaving: CEO – Jirka Rysavy ( 7.4 yrs ; -13.2% TSR)
Replaced by: James Colquhoun
James Colquhoun – age 41 – Director since May 2020. He founded, and since 2008 has served as the Chief Executive Officer of, Food Matters, a digital media and production company. He also founded Food Matters TV Pty Ltd (FMTV), a health and wellness SVOD (subscription video on demand) company, and served as FMTV’s Chief Executive Officer until its acquisition by Gaia in June 2019. During his tenure…read full bio

HEPION PHARMACEUTICALS INC (HEPA)
Leaving: CEO – Robert T Foster ( 5.2 yrs ; -66.6% TSR)
Replaced by: John T Cavan
John Cavan – Chief Financial Officer Mr. Cavan has been our Chief Financial Officer since March 2016. Previously, Mr. Cavan was a consultant with The Pine Hill Group where he was instrumental in completing several financial transactions, including initial public offerings, business combinations and strategic transactions. Prior to his role with the Pine Hill Group, he served as Chief Accounting Of…read full bio

LANDSTAR SYSTEM INC (LSTR)
Leaving: CEO – James B Gattoni ( 8.2 yrs ; 12.7% TSR)
Replaced by: Frank A Lonegro
Mr. Lonegro, age 55, is joining Landstar from Beacon Roofing Supply, Inc. (“Beacon”), where he currently serves as Executive Vice President and Chief Financial Officer. Beacon Roofing Supply is a Fortune 500 North American building products distribution company. Prior to working at Beacon, Mr. Lonegro worked for almost 20 years at CSX Corporation, a Fortune 250 rail transport…read full bio

THESEUS PHARMACEUTICALS INC (THRX)
Leaving: CEO – Timothy P Clackson ( 2.2 yrs ; -52.1% TSR)
Replaced by: TBD

 

CFO Moves

APYX MEDICAL CORP (APYX)
Leaving: CFO – Tara Semb ( 4.9 yrs ; -19.4% TSR)
Replaced by: Matthew Hill
Immediately prior to joining the Company, Mr. Hill, age 55, served as the Chief Financial Officer of PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech”), a clinical-stage immunotherapy company, where he led all aspects of the company’s budgeting, forecasting, financial management and reporting. Prior to joining PDS Biotech, he served as Chief Financial Officer of Strata …read full bio

ARTIVION INC (AORT)
Leaving: CFO – David Ashley Lee ( 23.7 yrs ; .9% TSR)
Replaced by: Lance A Berry
Mr. Berry, 51, most recently served from January 2019 until November 2020 as the Executive Vice President, Chief Financial and Operations Officer of Wright Medical Group N.V. (“Wright”), until Wright was acquired by Stryker in November 2020. Before that, Mr. Berry served as the Senior Vice President, Chief Financial Officer for Wright from 2009 to 2018, successfully spear-heading its m…read full bio

AXOGEN INC (AXGN)
Leaving: CFO – Peter J Mariani ( 7.8 yrs ; 2.4% TSR)
Replaced by: Nir Naor
Mr. Naor, 49, has over 20 years of global work experience in executive finance and accounting activities, primarily focused on the life sciences industry. From October 2022 to November 2023, Mr. Naor held advisory and short-term CFO roles at a number of growth companies. From December 2021 to October 2022, he served as the CFO of HMNC Brain Health while supporting their fund raising and IPO prepar…read full bio

CARGURUS INC (CARG)
Leaving: CFO – Jason Trevisan ( 1.2 yrs)
Replaced by: Elisa Palazzo
Ms. Palazzo, age 41, joins the Company from Talkspace, Inc., a healthcare software company, where she currently serves as Deputy Chief Financial Officer, a role she has held since April 2023, and as Senior Vice President of Finance, a role she assumed in 2021 as part of Hudson Executive Capital’s involvement in Talkspace, Inc. Between October 2020 and April 2023 she was a Senior Analyst…read full bio

COMPASS PATHWAYS PLC (CMPS)
Leaving: CFO – Mary -Rose Hughes ( .4 yrs *interim; )
Replaced by: Teri Loxam
Teri Loxam, age 51, has over 20 years of experience in the pharmaceutical and biotechnology sectors with diverse roles spanning strategy, investor relations, finance, and communications. Ms. Loxam served as Chief Financial Officer of Gameto, Inc., a privately held, clinical-stage biotechnology company from April 2023 until October 2023. Previously, Ms. Loxam served as Chief Financial Officer and C…read full bio

DHI GROUP INC (DHX)
Leaving: CFO – Art Zeile ( .3 yrs *interim; )
Replaced by: Muhle Raime Leeby
Ms. Leeby Muhle, 46, most recently served as Chief Strategy Officer and interim CFO at US Med-Equip, a company that provides life-saving medical equipment and solutions to hospitals across the nation, from November 2021 to November 2023. Prior to that, she operated Pelican Ventures, a consulting and advisory business, from April 2020 to November 2021. From October 2017 to April 2020, Ms. Leeb…read full bio

DIGITALBRIDGE GROUP INC (DBRG)
Leaving: CFO – Jacky Wu ( 3.8 yrs ; 13.4% TSR)
Replaced by: Thomas Mayrhofer
Mr. Mayrhofer brings more than two decades of robust financial and operational experience across the asset management industry. He spent nearly 18 years at The Carlyle Group in a variety of financial roles across all of the firm’s products—including private equity, energy, real estate and credit. He concluded his tenure at Carlyle as a Partner and CFO of the firm’s Private Equity busin…read full bio

L3HARRIS TECHNOLOGIES INC (LHX)
Leaving: CFO – Michelle L. Turner ( 1.9 yrs ; -3.6% TSR)
Replaced by: Kenneth L Bedingfield
Mr. Bedingfield, 51, joins L3Harris from Epirus, Inc. a privately held technology company developing software-defined counter-electronics effects and power management solutions for defense and commercial applications, where he most recently served as Chief Executive Officer since 2022 and as President, Chief Operating Officer and Chief Financial Officer from 2020 to 2022. He served as Corporate Vi…read full bio

PROVIDENT FINANCIAL HOLDINGS INC (PROV)
Leaving: CFO – Donavon P Ternes ( 23.2 yrs ; 3.8% TSR)
Replaced by: Tam B. Nguyen
Ms. Nguyen’s professional designations include Certified Public Accountant, Chartered Global Management Accountant, and Certified Management Accountant.  Her educational background includes a Master of Business Administration from California State University, San Marcos, and a Bachelor of Arts in Economics and a Bachelor of Science in Biochemistry/Cell Biology both from the University o…read full bio

SIMMONS FIRST NATIONAL CORP (SFNC)
Leaving: CFO – James M Brogdon ( .9 yrs ; -21.0% TSR)
Replaced by: Charles Daniel Hobbs
Mr. Hobbs is joining the Company and the Bank from Regions Bank (“Regions”), a commercial bank based in Alabama and a subsidiary of Regions Financial Corporation, where he has worked in finance roles since 2007 and, since 2019, served as Regions’ Executive Vice President and Head of Finance (and, prior to that, as its Consumer Chief Financial Officer, as well as other roles). As …read full bio

WALT DISNEY CO (DIS)
Leaving: CFO – Kevin A. Lansberry ( .4 yrs *interim; 1.6% TSR)
Replaced by: Hugh F Johnston
Mr. Johnston, 62, currently serves as Executive Vice President and Chief Financial Officer, from 2010, and Vice Chairman, from 2015, of PepsiCo, Inc. (“PepsiCo”). In addition to providing strategic financial leadership for PepsiCo in these roles, Mr. Johnston’s portfolio has included a variety of responsibilities, including leadership of PepsiCo’s information technology fun…read full bio

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.